Case Study: Genome.One protects critical IP and customer data with Guardicore Centra

How Guardicore’s tight microsegmentation and rule policy allow Genome.One to protect customer data and their own innovative IP.

Genome.One, a wholly owned subsidiary of Australia’s Garvan Institute of Medical Research, needed to protect its critical IP and customer data across a complex hybrid environment spanning on-prem data center infrastructure, AWS EC2, and Google Kubernetes workloads. The team wanted to enforce tight micro-segmentation, detect breaches in real time, and avoid the burden of managing multiple point security solutions and false-positive alerts. Guardicore was chosen to help address these challenges.

By deploying Guardicore Centra across its computing platforms, Genome.One gained a single, unified map of its network and workloads, improving visibility into how applications and data were being consumed and utilized. The Guardicore platform also integrated with DevOps orchestration via API and delivered advanced breach detection and response across both AWS and on-prem servers, helping secure sensitive research information and close key security gaps.

Genome.One

Liviu Constantinescu

Principal Software Engineer And DevOps Team Leader